Replies to post #226970 on NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

It would be interesting to see how if this treatment would improve outcomes for unmethylated patients who don't do so well on RT and CT.

[maverick_1]

Thanks Staccani: “The Company continues to make progress in its Phase 3 INTACT (INvestigation of TSC Against Cancerous Tumors) trial. It has completed the eight-patient open label dose-escalation run-in cohort and, with enrollment for this phase now closed, expects data on this group to be available this summer.”

DIFFERENT STROKES FOR DIFFERENT FOLKS